L Brčić1, A Barić2, S Gračan2, M Brekalo2, D Kaličanin1, I Gunjača1, V Torlak Lovrić2, S Tokić3, M Radman2, V Škrabić4, A Miljković5, I Kolčić5, M Štefanić6, L Glavaš-Obrovac3, D Lessel7, O Polašek5, T Zemunik1, M Barbalić1, A Punda2, V Boraska Perica8. 1. Department of Medical Biology, School of Medicine, University of Split, Šoltanska 2, 21000, Split, Croatia. 2. Department of Nuclear Medicine, University Hospital Split, Split, Croatia. 3. Department of Medical Chemistry, Biochemistry and Clinical Chemistry, Faculty of Medicine, University of Osijek, Osijek, Croatia. 4. Department of Pediatrics, University Hospital Split, Split, Croatia. 5. Department of Public Health, School of Medicine, University of Split, Split, Croatia. 6. Department of Nuclear Medicine and Oncology, Faculty of Medicine, University of Osijek, Osijek, Croatia. 7. Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. 8. Department of Medical Biology, School of Medicine, University of Split, Šoltanska 2, 21000, Split, Croatia. vboraska@mefst.hr.
Abstract
PURPOSE: Hashimoto's thyroiditis (HT) is the most common form of autoimmune thyroid diseases. Current knowledge of HT genetics is limited, and not a single genome-wide association study (GWAS) focusing exclusively on HT has been performed to date. In order to decipher genetic determinants of HT, we performed the first GWAS followed by replication in a total of 1443 individuals from Croatia. METHODS: We performed association analysis in a discovery cohort comprising 405 cases and 433 controls. We followed up 13 independent signals (P < 10-5) in 303 cases and 302 controls from two replication cohorts and then meta-analyzed results across discovery and replication datasets. RESULTS: We identified three variants suggestively associated with HT: rs12944194 located 206 kb from SDK2 (P = 1.8 × 10-6), rs75201096 inside GNA14 (P = 2.41 × 10-5) and rs791903 inside IP6K3 (P = 3.16 × 10-5). Genetic risk score (GRS), calculated using risk alleles of these loci, accounted for 4.82% of the total HT variance, and individuals from the top GRS quartile had 2.76 times higher odds for HT than individuals from the lowest GRS quartile. CONCLUSIONS: Although discovered loci are implicated with susceptibility to HT for the first time, genomic regions harboring these loci exhibit good biological candidacy due to involvement in the regulation of the thyroid function and autoimmunity. Additionally, we observe genetic overlap between HT and several related traits, such as hypothyroidism, Graves' disease and TPOAb. Our study adds a new knowledge of underlying HT genetics and sets a firm basis for further research.
PURPOSE:Hashimoto's thyroiditis (HT) is the most common form of autoimmune thyroid diseases. Current knowledge of HT genetics is limited, and not a single genome-wide association study (GWAS) focusing exclusively on HT has been performed to date. In order to decipher genetic determinants of HT, we performed the first GWAS followed by replication in a total of 1443 individuals from Croatia. METHODS: We performed association analysis in a discovery cohort comprising 405 cases and 433 controls. We followed up 13 independent signals (P < 10-5) in 303 cases and 302 controls from two replication cohorts and then meta-analyzed results across discovery and replication datasets. RESULTS: We identified three variants suggestively associated with HT: rs12944194 located 206 kb from SDK2 (P = 1.8 × 10-6), rs75201096 inside GNA14 (P = 2.41 × 10-5) and rs791903 inside IP6K3 (P = 3.16 × 10-5). Genetic risk score (GRS), calculated using risk alleles of these loci, accounted for 4.82% of the total HT variance, and individuals from the top GRS quartile had 2.76 times higher odds for HT than individuals from the lowest GRS quartile. CONCLUSIONS: Although discovered loci are implicated with susceptibility to HT for the first time, genomic regions harboring these loci exhibit good biological candidacy due to involvement in the regulation of the thyroid function and autoimmunity. Additionally, we observe genetic overlap between HT and several related traits, such as hypothyroidism, Graves' disease and TPOAb. Our study adds a new knowledge of underlying HT genetics and sets a firm basis for further research.
Authors: M Cvek; A Punda; M Brekalo; M Plosnić; A Barić; D Kaličanin; L Brčić; M Vuletić; I Gunjača; V Torlak Lovrić; V Škrabić; V Boraska Perica Journal: J Endocrinol Invest Date: 2021-10-06 Impact factor: 4.256
Authors: Christina Ellervik; Samia Mora; Aleksander Kuś; Bjørn Åsvold; Eirini Marouli; Panos Deloukas; Rosalie B T M Sterenborg; Alexander Teumer; Stephen Burgess; Maria Sabater-Lleal; Jennifer Huffman; Andrew D Johnson; David-Alexandre Trégouet; Nicolas L Smith; Marco Medici; Paul S DeVries; Daniel I Chasman; Alisa D Kjaergaard Journal: Thyroid Date: 2021-08-05 Impact factor: 6.506
Authors: Alisa D Kjaergaard; Eirini Marouli; Areti Papadopoulou; Panos Deloukas; Aleksander Kuś; Rosalie Sterenborg; Alexander Teumer; Stephen Burgess; Bjørn O Åsvold; Daniel I Chasman; Marco Medici; Christina Ellervik Journal: Eur J Epidemiol Date: 2021-02-06 Impact factor: 12.434
Authors: Liliana R Santos; Cecília Durães; Panos G Ziros; Ana Pestana; César Esteves; Celestino Neves; Davide Carvalho; Massimo Bongiovanni; Cédric O Renaud; Dionysios V Chartoumpekis; Ioannis G Habeos; Manuel Sobrinho Simões; Paula Soares; Gerasimos P Sykiotis Journal: Thyroid Date: 2019-09 Impact factor: 6.568
Authors: Luka Brčić; Ana Barić; Benjamin Benzon; Marko Brekalo; Sanda Gračan; Dean Kaličanin; Veselin Škrabić; Tatijana Zemunik; Maja Barbalić; Ivana Novak; Valdi Pešutić Pisac; Ante Punda; Vesna Boraska Perica Journal: Sci Rep Date: 2020-02-04 Impact factor: 4.379
Authors: Dean Kaličanin; Luka Brčić; Katija Ljubetić; Ana Barić; Sanda Gračan; Marko Brekalo; Vesela Torlak Lovrić; Ivana Kolčić; Ozren Polašek; Tatijana Zemunik; Ante Punda; Vesna Boraska Perica Journal: Sci Rep Date: 2020-06-30 Impact factor: 4.379